Illustration by Michele Marconi

AI@2D group, is using machine-learning technology with high quality dataset to develop generative and predictive models for improving the drug discovery process.

Bringing novel drugs to market is an expensive and time-consuming process, mainly due to the high costs associated with clinical trials. In recent years, artificial intelligence (AI) has been increasingly used in drug discovery to reduce design-make-test-analysis cycle time and increase the success rate.

With the AI-driven platform, new therapeutics will be discovered and developed to address the clinical needs.